ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation

PLoS One. 2015 May 8;10(5):e0125638. doi: 10.1371/journal.pone.0125638. eCollection 2015.

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a complex etiology and pathology that makes the development of new therapies difficult. ACTH has neurotrophic and myotrophic effects, but has not been tested in an ALS mouse model. The G93A-SOD1 mouse model of ALS was used to test the ability of this drug to delay ALS-like symptoms. We showed that within a specific dose range, ACTH significantly postponed the disease onset and paralysis in the mouse model. To our surprise and of greater significance is that ACTH significantly reduced the levels of soluble SOD1 in the spinal cord and CNS tissues of G93A-SOD1 treated mice as well as cultured fibroblasts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / pharmacology
  • Adrenocorticotropic Hormone / therapeutic use*
  • Amyotrophic Lateral Sclerosis / metabolism
  • Amyotrophic Lateral Sclerosis / pathology
  • Amyotrophic Lateral Sclerosis / prevention & control*
  • Animals
  • Body Weight / drug effects
  • Cell Line
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Motor Activity / drug effects
  • Motor Neurons / metabolism
  • Mutation
  • Spinal Cord / metabolism
  • Superoxide Dismutase / analysis
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism*
  • Superoxide Dismutase-1
  • Survival Rate

Substances

  • SOD1 protein, human
  • Adrenocorticotropic Hormone
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1

Grants and funding

The work was supported in part by Questcor Pharmaceuticals. Additional support was from the Les Turner ALS Foundation, the Les Turner Foundation/Herbert C. Wenske Professorship (to TS), Harold Post Research Professorship (to TS), Vena E. Schaff ALS Research Fund, the S.W. Ranson Fund in ALS Research, and the Foglia Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.